Thiogenesis Therapeutics, Corp. announced the appointment of Dr. Vincent Stanton Jr., MD to Its Scientific Advisory Board.). Dr. Stanton was a co-founder of Thiogenesis Therapeutics Inc., dating back to February 2016.

Dr. Vincent Stanton Jr., MD is an entrepreneur and consultant who has worked for a variety of diagnostics and therapeutics clients on drug development and personalized medicine projects. He was formerly Senior Vice President of Research at Variagenics, an early genomics firm where he helped guide research from startup through IPO, including several major shifts in scientific and business strategy. After medical school, Dr. Stanton completed a pathology residency at Brigham and Women's Hospital followed by postdoctoral training at Dana-Farber Cancer Institute and MIT.